| 總結: | Choroideremia (CHM) is a rare X-linked chorioretinal dystrophy, affecting the photoreceptors, retinal pigment epithelium (RPE) and choroid, with no approved therapy. CHM is caused by mutations in the <i>CHM</i> gene, which encodes the ubiquitously expressed Rab escort protein 1 (REP1). REP1 is involved in prenylation, a post-translational modification of Rab proteins, and plays an essential role in intracellular trafficking. In this study, we examined oxidative and endoplasmic reticulum (ER) stress pathways in <i>chm<sup>ru848</sup></i> zebrafish and <i>CHM<sup>Y42X</sup></i> patient fibroblasts, and screened a number of neuroprotectants for their ability to reduce stress. The expression of the oxidative stress markers <i>txn</i>, <i>cat</i> and <i>sod3a</i>, and the ER stress markers <i>bip</i>, <i>atf4</i> and <i>atf6</i>, were dysregulated in <i>chm<sup>ru848</sup></i> fish. The expression of <i>SOD2</i> was also reduced in <i>CHM<sup>Y42X</sup></i> fibroblasts, along with reduced <i>BIP</i> and increased <i>CHOP</i> expression. The lack of REP1 is associated with defects in vesicular trafficking, photoreceptor outer segment phagocytosis and melanosome transport, leading to increased levels of stress within the retina and RPE. Drugs targeting oxidative and ER stress pathways represent novel therapeutic avenues.
|
|---|
